Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyVax Vaccine in Follicular Non-Hodgkin's Lymphoma
NCT00017290Phase 3Unknown
- Sponsor
- Genitope Corporation
- Start
- Nov 2000
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of Autologous FL vaccine in follicular lymphoma (FL), sponsored by Genitope Corporation. Status: unknown.
02
Drugs
Autologous FL vaccine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00017290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017290.